SP-101

DB18274InvestigationalGene Therapies

SP-101: Overview.

Mechanism: Pharmacologically active on Epidermal growth factor receptor and NMDA receptor
Curator reviewed
Code names: SP-101

Resolves to

Targets

What you can answer from here — as of October 05, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with SP-101, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.